Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nahid Moradi
Observed name:
Moradi, Nahid
Institution:
The University of Melbourne
Observed institutions:
Islamic Azad University Roudehen Branch,
The Royal Melbourne Hospital,
The University of Melbourne,
Queen's University,
Queens University,
Endocrinology and Metabolism Clinical Sciences Institute,
Osteoporosis Research Center,
Tehran University of Medical Sciences
show all 8
ORCID:
0000-0001-6253-4487
Observed ORCID:
0000-0001-6253-4487
OpenAlex ID:
A5021243455
Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
2020
·
Ali Khatibi
, Nahid Moradi
, et al.
·
Frontiers in Psychiatry
·
37
PDF
Protocol for a multicentre, prospective cohort study of clinical, proteomic and genomic patterns associated with osteoporosis to develop a multidimensional fracture assessment tool: the PoCOsteo Study
2020
·
Patricia Khashayar
, Hans Peter Dimai
, et al.
·
BMJ Open
·
17
PDF
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018
2021
·
Nahid Moradi
, Sifat Sharmin
, et al.
·
CNS Drugs
·
10
Evaluation of the effects of psychotherapy on anxiety among mothers of children with leukemia.
2014
·
Shiva Nazari
, Nahid Moradi
, et al.
·
Europe PMC (PubMed Central)
·
8
Disability accrual in primary and secondary progressive multiple sclerosis
2023
·
Sam Harding-Forrester
, Izanne Roos
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
7
PDF
Investigating comparability of quantitative computed tomography with dual energy x-ray absorptiometry in assessing bone mineral density of patients with chronic spinal cord injury
2017
·
Hamid Reza Haghighat Khah
, Nahid Moradi
, et al.
·
Spinal Cord
·
7
External validation of a clinical prediction model in multiple sclerosis
2022
·
Nahid Moradi
, Sifat Sharmin
, et al.
·
Multiple Sclerosis Journal
·
3
Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
2026
·
Nahid Moradi
, Sifat Sharmin
, et al.
·
European Journal of Neurology
·
2
PDF
A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran.
2019
·
Seyed Massood Nabavi
, Roya Abolfazli
, et al.
·
PubMed Central
·
2
Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis
2018
·
Ali Khatibi
, Nahid Moradi
, et al.
·
1
The Potential of Cordyceps sinensis as a Novel Treatment for Reducing Muscle Pain in Fibromyalgia
2025
·
Dana Abughaduma
, Nahid Moradi
, et al.
·
UTSC s Journal of Natural Sciences
PDF
Contribution of bone turnover markers (BTMs) and vitamin D to bone health in Iranian elderly women
2024
·
Safoora Gharibzadeh
, Noushin Fahimfar
, et al.
·
Journal of Diabetes & Metabolic Disorders
Biomarkers of Treatment Response in Multiple Sclerosis
2023
·
Moradi, Nahid
·
Minerva Access (University of Melbourne)
2413 Does serum neurofilament light chain level contribute to the prediction of treatment response in multiple sclerosis?
2022
·
Nahid Moradi
, Sifat Sharmin
, et al.
·
BMJ Neurology Open
PDF
Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis (2901)
2021
·
Sam Harding-Forrester
, Izanne Roos
, et al.
·
Neurology
Fear of Relapse Scale
2020
·
Ali Khatibi
, Nahid Moradi
, et al.
·
PsycTESTS Dataset
Show more works
View as search
Works count:
18
Citation count:
94
H-index:
6
I10-index:
3
Year
Topic
Type
